ARTELO BIOSCIENCES INC (ARTL:NASDAQ)

$0.719 0.0018 (0.251%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 69

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ARTELO BIOSCIENCES INC (ARTL:NASDAQ) News Sources

Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success

10-06-2026

yahoo.com

Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026

29-06-2026

yahoo.com

Artelo Biosciences Presents Evidence for a Common Lipid-Signaling Link Across Multiple Potential Indications for Its FABP5 Inhibitor Platform at ICRS 2026

30-06-2026

yahoo.com

Artelo Biosciences Announces New Data Supporting ART26.12 as a Potential First-in-Class Therapy for Chronic Pain associated with Spinal Cord Injury

01-07-2026

yahoo.com

Artelo Biosciences Announces Positive Results with ART27.13 in a Nonclinical Model of Paclitaxel-Induced Peripheral Neuropathy

13-07-2026

yahoo.com

Artelo Biosciences Issues Reminder to Shareholders to Vote in Advance of Annual Meeting on July 17, 2026

14-07-2026

yahoo.com

Artelo Biosciences Announces Results from a Nonclinical Osteoarthritis Study Supporting ART26.12 as a Potential First-in-Class New Therapy for Chronic Pain Conditions

16-07-2026

yahoo.com

New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition

22-07-2026

yahoo.com

Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results

13-08-2026

yahoo.com

Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies

17-08-2026

yahoo.com

ARTELO BIOSCIENCES INC (ARTL:NASDAQ) Sentiment Trend

0 25 50 75 100 78 78 83 85 79 3 83 57 88 56 10-06-2026 29-06-2026 30-06-2026 01-07-2026 13-07-2026 14-07-2026 16-07-2026 22-07-2026 13-08-2026 17-08-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ARTELO BIOSCIENCES INC (ARTL:NASDAQ) FAQs

toggle

What is the current price of ARTELO BIOSCIENCES INC (ARTL:NASDAQ)?

The current price of ARTELO BIOSCIENCES INC (ARTL:NASDAQ) is $0.719.


toggle

ARTELO BIOSCIENCES INC (ARTL:NASDAQ) absolute price change since previous trading day?

The absolute price change of ARTELO BIOSCIENCES INC (ARTL:NASDAQ) since the previous trading day is $0.0018.


toggle

ARTELO BIOSCIENCES INC (ARTL:NASDAQ) percentage price change since previous trading day?

The percentage price change of ARTELO BIOSCIENCES INC (ARTL:NASDAQ) since the previous trading day is 0.251%.


toggle

What is the most recent average sentiment score for ARTELO BIOSCIENCES INC (ARTL:NASDAQ)?

The most recent average sentiment score for ARTELO BIOSCIENCES INC (ARTL:NASDAQ) is 69 out of 100.


toggle

What is the most recent average sentiment for ARTELO BIOSCIENCES INC (ARTL:NASDAQ)?

The most recent sentiment for ARTELO BIOSCIENCES INC (ARTL:NASDAQ) is .


SEC-8K** Filing Available For ARTELO BIOSCIENCES INC (ARTL:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.